A Randomized Study of Amplimexon (Imexon) With Gemcitabine in Pancreatic Cancer

Clinical trial NCT00637247 · COMPLETED

Trial details

NCT number: NCT00637247
Sponsor: AmpliMed Corporation
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Pancreatic Neoplasms

Start date: 2008-04-01
Primary completion: 2010-05-01
Enrollment: 142

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.